Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Attention-deficit/hyperactivity disorder (ADHD) is a risk factor for problematic cannabis use. However, clinical and anecdotal evidence suggest an increasingly popular perception that cannabis is therapeutic for ADHD, including via online resources. Given that the Internet is increasingly utilized as a source of healthcare information and may influence perceptions, we conducted a qualitative analysis of online forum discussions, also referred to as threads, on the effects of cannabis on ADHD to systematically characterize the content patients and caregivers may encounter about ADHD and cannabis.
Methods: A total of 268 separate forum threads were identified. Twenty percent (20%) were randomly selected, which yielded 55 separate forum threads (mean number of individual posts per forum thread = 17.53) scored by three raters (Cohen's kappa = 0.74). A final sample of 401 posts in these forum threads received at least one endorsement on predetermined topics following qualitative coding procedures.
Results: Twenty-five (25%) percent of individual posts indicated that cannabis is therapeutic for ADHD, as opposed to 8% that it is harmful, 5% that it is both therapeutic and harmful, and 2% that it has no effect on ADHD. This pattern was generally consistent when the year of each post was considered. The greater endorsement of therapeutic versus harmful effects of cannabis did not generalize to mood, other (non-ADHD) psychiatric conditions, or overall domains of daily life. Additional themes emerged (e.g., cannabis being considered sanctioned by healthcare providers).
Conclusions: Despite that there are no clinical recommendations or systematic research supporting the beneficial effects of cannabis use for ADHD, online discussions indicate that cannabis is considered therapeutic for ADHD-this is the first study to identify such a trend. This type of online information could shape ADHD patient and caregiver perceptions, and influence cannabis use and clinical care.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882033 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0156614 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Case Report: Effect of medicinal cannabis on fitness to drive in a patient with Tourette Syndrome and ADHD.
Front Psychiatry
August 2025
Clinic of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany.
Background: Tourette Syndrome (TS) is a childhood onset chronic disorder in which motor and vocal tics co-occur. Cannabinoids are a potential therapeutic option for otherwise treatment resistant patients. However, there is an ongoing debate regarding potential side effects.
View Article and Find Full Text PDFNeurodevelopmental effects of perinatal exposure to cannabis on progeny: A narrative review.
Drug Alcohol Depend Rep
September 2025
Department of Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, FL, United States.
Objective: The certainty of effects on neurodevelopmental outcomes resulting from perinatal cannabis exposure is yet to be established. This review synthesizes current clinical and preclinical evidence on neurodevelopment and related functional outcomes in offspring exposed to cannabis during pregnancy or early childhood. Additionally, gaps in the literature and suggestions to bridge these gaps are provided.
View Article and Find Full Text PDFCannabis Use in a Community-Based Sample of Adults Diagnosed With ADHD: Prevalence, Impact on Symptoms, and Stimulant Side Effects.
J Atten Disord
August 2025
Thomas Jefferson University, Philadelphia, PA, USA.
Aim: Assess prevalence and correlates of cannabis use in adults with attention-deficit/hyperactivity disorder (ADHD) and explore its impact on comorbidities, symptoms, and side effects of prescription stimulants.
Methods: An anonymous online survey (April to July 2023) was emailed to 9,274 potential adult participants with a documented ADHD diagnosis, based on ICD-10 codes in the electronic medical record, which was secondarily verified by self-report. A total of 900 participants completed the survey.
Frequency of body focused repetitive behaviors and comparison to self-injurious behaviors in patients with tic disorders.
Sci Rep
August 2025
Clinic of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
The majority of patients with chronic tic disorders suffer from psychiatric comorbidities, most frequently attention-deficit/hyperactivity disorder (ADHD), obsessive-compulsive disorder (OCD), depression, and anxiety. While characteristics of these psychiatric disorders are widely known, other comorbidities including self-injurious behaviors (SIB) and body focused repetitive behaviors (BFRB) are still under-investigated. Currently, there is a controversial discussion whether BFRB and SIB belong to the same spectrum because of clinical similarities or they represent distinct entities.
View Article and Find Full Text PDFMood instability as a transdiagnostic predictor of cannabis use in attention-deficit/hyperactivity disorder and depression: A Natural Language Processing analysis of electronic health records from 13,025 adolescents.
Eur Psychiatry
August 2025
CAMHS Digital Lab, King's Maudsley Partnership, King's College London and South London and the Maudsley NHS Foundation Trust, London, UK.